Featured Research

from universities, journals, and other organizations

Protein Thought To Promote Cancer Instead Functions As Tumor Suppressor

Date:
July 8, 2008
Source:
UT Southwestern Medical Center
Summary:
A protein previously thought to promote colorectal cancer instead suppresses the growth of human cancer cells in culture, researchers have found.

A research team led by Dr. Lawrence Lum (right) and including Dr. Wei Tang has discovered that a protein previously thought to promote colorectal cancer instead suppresses the growth of human cancer cells in culture.
Credit: UT Southwestern Medical Center

A protein previously thought to promote colorectal cancer instead suppresses the growth of human cancer cells in culture, researchers at UT Southwestern Medical Center have found.

"This finding reshapes a fundamental model of how colorectal cancer arises," said Dr. Lawrence Lum, assistant professor of cell biology at UT Southwestern and senior author of the study, which appears online today and in a future issue of the Proceedings of the National Academy of Sciences.

Approximately 90 percent of colorectal cancers are caused by a biochemical malfunction that arises from mutations in a gene that activates a gene called TCF7L2, Dr. Lum said. As a result, TCF7L2 has been suspected of helping to trigger colorectal cancer.

In the current study, the researchers used a novel genetic screening approach known as RNAi mediated interference, or RNAi, to identify genes that contributed to this malfunction.

The researchers employed more than 80,000 small snippets of chemically synthesized RNAs (ribonucleic acids) known as "small interfering RNAs" or siRNAs, that are each capable of inactivating a specific gene. The researchers mixed these siRNAs with specially engineered human cancer cells that glowed when the cancer-causing malfunction is activated. When an siRNA made a cell glow, the researchers were able to flag the gene as a candidate cancer gene.

As the researchers examined the genes of interest more closely, they unexpectedly found that a gene called TCF7L2, which had been thought to boost malignant cell growth, instead suppressed it. When the gene was inactivated, human colorectal cancer cells grew more rapidly in culture and emitted a stronger glow.

"The function of TCF7L2 in cancer was previously determined from studies in animals but no one has genetically tested its role in human colorectal cancer cells before," said Dr. Lum, who is a Virginia Murchison Linthicum Scholar in Medical Research. "Prior to the advent of RNAi technology, this was very difficult to do in human cultured cells."

The next step is to understand more fully all the steps in the biochemical pathway involved in controlling the action of TCF7L2. This knowledge could then be used to identify new therapeutic targets for treating colorectal cancer. Therapeutic strategies derived from such studies may also be useful in treating type II diabetes, for which risk is strongly associated with mutations in TCF7L2, Dr. Lum said.

Dr. Lum noted that the findings about TCF7L2 show the effectiveness of this high throughput screening technique, which can quickly and systematically check many thousands of genes.

The success of this relatively new screening method for identifying candidate cancer genes demonstrates its usefulness to understanding human disease, Dr. Lum said.

"It's a way to analyze human gene action directly in human tissue at a genome-scale," he said.

Other UT Southwestern researchers involved in the study were Dr. Wei Tang, postdoctoral researcher in cell biology; graduate student Michael Dodge; former laboratory technician Deepika Gundapaneni; Dr. Carolyn Michnoff, former manager of the High-Throughput Screening facility; and Dr. Michael Roth, professor of biochemistry.

The work was supported by the National Institutes of Health, the American Cancer Society, and the Welch Foundation.


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

UT Southwestern Medical Center. "Protein Thought To Promote Cancer Instead Functions As Tumor Suppressor." ScienceDaily. ScienceDaily, 8 July 2008. <www.sciencedaily.com/releases/2008/07/080707171734.htm>.
UT Southwestern Medical Center. (2008, July 8). Protein Thought To Promote Cancer Instead Functions As Tumor Suppressor. ScienceDaily. Retrieved September 3, 2014 from www.sciencedaily.com/releases/2008/07/080707171734.htm
UT Southwestern Medical Center. "Protein Thought To Promote Cancer Instead Functions As Tumor Suppressor." ScienceDaily. www.sciencedaily.com/releases/2008/07/080707171734.htm (accessed September 3, 2014).

Share This



More Health & Medicine News

Wednesday, September 3, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Doctors Fear They're Losing Battle Against Ebola

Doctors Fear They're Losing Battle Against Ebola

AP (Sep. 2, 2014) As a third American missionary is confirmed to have contracted Ebola in Liberia, doctors on the ground in West Africa fear they're losing the battle against the outbreak. (Sept. 2) Video provided by AP
Powered by NewsLook.com
Tech Giants Bet on 3D Headsets for Gaming, Healthcare

Tech Giants Bet on 3D Headsets for Gaming, Healthcare

AFP (Sep. 2, 2014) When Facebook acquired the virtual reality hardware developer Oculus VR in March for $2 billion, CEO Mark Zuckerberg hailed the firm's technology as "a new communication platform." Duration: 02:24 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins